The DEA banned a drug some opioid users called a miracle
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
Read the full story on Ars Technica.
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
Read the full story on Ars Technica.
This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they’re going to change your life. Opt in for Optimizer here. “How does that make you feel?” I get asked this a lot in therapy.
Some tried to co-op the sci-fi franchise as its own but, ultimately, there’s a new hope once again.
IOI has revealed the behind-the-scenes process for selecting Hitman World of Assassination’s Elusive Targets and how it designs their special missions.
First mistaken for space junk, 2026 QQ8 has turned out to be a temporary companion to Earth.
Bluetooth HDT’s rollout will benefit a wide range of wireless devices and how they communicate.
Sequoia is consolidating into a smaller, Bay Area–centered firm, shutting down the programs and offices it built during a 20-year expansion while announcing roughly $10 billion in new funds.
Techniques included laptop infections, compromised internal tooling, and fake job interviews.
After 45 minutes behind the wheel, I am more optimistic about the $25,000 EV.
State tries to obtain broadband funds despite rejecting Trump admin condition.
Russia tries to fix exposed digital infrastructure as data center war backfires.
69 active sources
24 Turkish · 45 English
All sources